The post-Figma question: Who’s next?

Green floats the idea of startups thinking of an IPO as the Series A of their new lives in the public markets—a notion she thinks could be “a motivator to people’s willingness, and maybe even eagerness, to go public.” (As if on cue, HeartFlow, a medical technology company, filed an S-1 for its IPO at a $1.3 billion valuation the day after Figma’s debut.)

source